tetradecanoylphorbol acetate has been researched along with melphalan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barker, E; Baumgartel, BA; Mokyr, MB; Weiskirch, LM | 1 |
| Frankfurt, OS; Seckinger, D; Sugarbaker, EV | 1 |
| Dammacco, F; Miglietta, A; Perfetto, SC | 1 |
| Buthmann, U; Freund, M; Kleine, HD; Volk, J | 1 |
| Bártová, E; Hájek, R; Harnicarová, A; Kozubek, S; Krejcí, J; Kůrová, J; Legartová, S; Uhlírová, R | 1 |
7 other study(ies) available for tetradecanoylphorbol acetate and melphalan
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers.
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; CD8 Antigens; Cell Line; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Drug Synergism; Female; In Vitro Techniques; Ionomycin; Lymphocyte Depletion; Melphalan; Mice; Mice, Inbred BALB C; Phagocytes; Plasmacytoma; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymoma; Time Factors | 1991 |
Intercellular transfer of drug resistance.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Communication; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; DNA; DNA Damage; Drug Resistance; Female; Flow Cytometry; Glutathione; Humans; In Vitro Techniques; Melphalan; Methionine Sulfoximine; Ovarian Neoplasms; Tetradecanoylphorbol Acetate | 1991 |
Impaired chemiluminescence response by neutrophils in patients with multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Luminescent Measurements; Melphalan; Multiple Myeloma; Myeloma Proteins; Neutrophils; Oxygen Consumption; Paraproteinemias; Peroxidase; Prednisone; Tetradecanoylphorbol Acetate; Vincristine; Zymosan | 1986 |
Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Escherichia coli; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Prognosis; Respiratory Burst; Tetradecanoylphorbol Acetate | 2000 |
Nuclear organization of PML bodies in leukaemic and multiple myeloma cells.
Topics: Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Flow Cytometry; Gamma Rays; HL-60 Cells; Humans; Intranuclear Inclusion Bodies; K562 Cells; Leukemia, Promyelocytic, Acute; Melphalan; Multiple Myeloma; Tetradecanoylphorbol Acetate; Tretinoin; U937 Cells | 2008 |